Episode Summary
Executive Summary: The conversation with Matthew Cobb examines the promise and peril of genetic engineering, arguing that while gene editing has transformed medicine and biology, three areas—gain-of-function pathogen research, heritable human genome editing, and gene drives—pose serious regulatory and ethical risks. Cobb stresses that these technologies are powerful but often poorly governed, making global oversight essential.
Main Topics: Gene editing as a transformative technology (Priority: 5/5): Cobb explains how genetic engineering has revolutionized medicine and science, from recombinant insulin to more efficient drug synthesis and basic biological research, while noting that technology can be applied in unintended ways outside the lab. Gain-of-function research and bioweapon risk (Priority: 5/5): He argues that making pathogens more dangerous—especially airborne or vaccine-resistant viruses—creates avoidable risk, citing historic concerns, lab leaks, and the lack of demonstrated benefit from such work. Heritable human genome editing and the CRISPR babies case (Priority: 5/5): Cobb condemns editing embryos for heritable changes as unnecessary, unsafe, and ethically dubious, using He Jiankui’s experiment as the clearest warning that ambition can outrun science and regulation. Gene drives and ecological intervention (Priority: 5/5): The discussion turns to using gene drives to alter or eliminate mosquito populations to fight malaria. Cobb warns that releasing self-propagating edits into ecosystems could have irreversible and poorly understood consequences. Regulation, transparency, and global governance (Priority: 4/5): A central theme is that existing frameworks are inadequate: the Biological Weapons Convention lacks enforcement, and the U.S. resists stronger international inspection powers, leaving dangerous research under-policed. Public consent and the limits of scientific expertise (Priority: 4/5): Cobb argues these decisions are too important for scientists alone, emphasizing the need for democratic debate, informed consent, and political accountability because technical capability does not equal moral permission.
Key Arguments: Genetic engineering has produced major benefits, including safer human insulin and more efficient drug synthesis. The greatest concern is not amateur biohackers but established labs and states where advanced research can leak or be misused. Gain-of-function research offers little proven public-health benefit relative to the risk it creates. Heritable genome editing is ethically problematic because it is unnecessary in most cases, unsafe, and often aimed at preference rather than treatment. CRISPR is less precise in real biological systems than the popular metaphor of 'molecular scissors' suggests; mosaicism and off-target effects remain serious problems. Gene drives could spread through wild populations in ways that are extremely difficult or impossible to reverse. Current international agreements are too weak to prevent misuse; effective oversight would require real inspection and sanction powers. Public participation matters because these technologies affect whole societies and ecosystems, not just individual laboratories.
Data Points: Marburg virus lethality: described as 'much more dangerous' than Ebola - Opening anecdote about a Soviet researcher infected with Marburg virus Age of genetic engineering: about 50 years - Cobb says precise gene editing emerged 50 years ago and has been transformational Insulin production transition: 1978 - Early recombinant human insulin made in microbes Human insulin structure difference: 1 extra amino acid in pig/cow insulin - Explains why animal-derived insulin could cause allergic responses Anti-cancer drug productivity gain: 1,000 times more productive - New method using plant genes in yeast to synthesize a drug COVID-era PCR: PCR tests during the COVID pandemic - Used to illustrate laboratory complexity and the difficulty of getting protocols to work Bioweapons convention adoption: Signed in 1972; came into function in 1975 - Cobb says the treaty is toothless without inspections or sanctions Gain-of-function pause duration: 8 weeks (became about 8 months) - Scientists paused after realizing the implications of airborne H5N1 work Bird flu danger level: about 100 times more dangerous than COVID-19 - Cobb characterizes H5N1 as highly lethal if made airborne Malaria mortality: half a million people per year - Used to justify interest in mosquito control and gene drives Target Malaria security idea: up to 60 checkpoints - Scientists proposed extensive decision gates before any release CRISPR babies: 2 embryos announced, later a 3rd baby revealed - He Jiankui’s experiment was later found to have involved three children Human genome size: 3.5 billion bits of letters of DNA - Used to highlight how many opportunities there are for error in editing Huntington’s disease typical onset: late 30s to early 40s - Example of a severe dominant genetic disease Mosquito cage eradication: about 8 generations - Gene drive experiments could eliminate a cage population in lab settings Biotech governance timing: 4 pauses/moratoria in genetics - Cobb says genetics is unique in having repeatedly called for research pauses
Pivotal Quotes: "We are gods, we're just shitty gods" — Matthew Cobb quoting Eric Weinstein: Used to frame the mismatch between technological power and human wisdom "Your scientists were so busy thinking about whether they could, they didn't think about whether they should" — Matthew Cobb citing Jurassic Park: Illustrates the ethical warning at the center of gene-editing debates "all these things are held in laboratories, just like there are two stocks of smallpox" — Matthew Cobb: On why dangerous biological materials remain a continuing risk even when officially controlled
Implications: Listeners should see genetic engineering as profoundly useful but governance-deficient. The future risk is not the science itself, but misuse, weak oversight, and irreversible ecological or human consequences without strong global regulation.
About Modern Wisdom
Chris Williamson in long-form conversation with the world's most interesting people - psychologists, scientists, authors, comedians and entrepreneurs - on life, science, health, fitness, business and philosophy.